// App-Quantinova.ai

2128 : Consistent Long-Term Guselkumab Efficacy Across Psoriatic Arthritis Domains Irrespective of Baseline Patient Characteristics

Researchers

Presenter

  • Iain B McInnes

Principal Investigators

  • John Tesser

  • Elena Schiopu

  • Joseph Merola

  • Soumya Chakravarty

  • Emmanouil Rampakakis

  • Natalie Shiff

  • Alexa Kollmeier

  • Xie L Xu

  • May Shawi

  • Frederic Lavie

  • Paul Bird

  • Philip J Mease

Medical Centers

  • Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, United Kingdom

  • Arizona Arthritis & Rheumatology Associates, Glendale, AZ, United States

  • Michigan Medicine Rheumatology Clinic – Taubman Center, Ann Arbor, MI

  • Brigham and Women's Hospital and Harvard Medical School, Boston, MA

  • Janssen Scientific Affairs, LLC; Drexel University College of Medicine, Horsham; Philadelphia, PA

  • McGill University, Department of Pediatrics and JSS Medical Research, Montréal, QC, Canada

  • Janssen Scientific Affairs, LLC; Community Health and Epidemiology, University of Saskatchewan, Philadelphia, PA

  • Janssen Research & Development, San Diego, CA

  • Janssen Research & Development, LLC, Spring House, PA/San Diego, Spring House, PA/San Diego, CA

  • Immunology Global Medical Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson, Horsham, PA, USA

  • The Janssen Pharmaceutical Companies of Johnson & Johnson, Paris, France, Paris, France

  • The University of New South Wales, NSW, Australia

  • Swedish Medical Center/Providence St. Joseph Health, Seattle, WA

Locations

  • United Kingdom

  • United States

  • Canada

  • France

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

  • Dermatology

Disease

  • Psoriatic arthritis

  • Dactylitis

  • Inflammatory Arthritis

  • Psoriasis

Biomarkers

  • C reactive protein

Drug/Treatment

  • guselkumab (IV)

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved